FDA Approved: ILUMYA — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved ILUMYA (tildrakizumab-asmn) in an original application from Sun Pharmaceutical Industries. The approval covers its use for plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Ilumya (tildrakizumab)

Snippet

ORIG AP for ILUMYA (TILDRAKIZUMAB-ASMN)